Bell Kristy, Dykas Claire, Muckian Bridget, Williams Brooke, Rainey Hope, Comberg Maggy, Mora Mary, Owen Katherine A, Lipsky Peter E
AMPEL BioSolutions LLC, Charlottesville, Virginia.
ACR Open Rheumatol. 2022 Feb;4(2):99-109. doi: 10.1002/acr2.11370. Epub 2021 Nov 10.
Patient-reported outcomes (PROs) can provide critical information concerning the impact of a disease on an individual. Mobile technology to collect PRO data in an electronic format (ePRO) allows for frequent assessment in the person's regular environment. The goal of this study was to assess the compliance with a phone application (app) and validate ePRO information in individuals with systemic lupus erythematosus (SLE).
A smartphone app that collects ePRO data from various clinical instruments was developed. Information was collected by both an ePRO and a paper-administered instrument as part of a multicenter randomized interventional clinical trial of patients meeting American College of Rheumatology (ACR) criteria for the classification of SLE. To determine agreement between PRO information collected in the different formats, intraclass correlation coefficients (ICCs), paired Student's t tests, and Bland-Altman plots were evaluated. Compliance and Cronbach's alpha were also assessed as a measure of survey reliability.
For the 62 subjects from diverse ancestral backgrounds, compliance with ePRO completion was high (more than 75%). Cronbach alpha values for PROs indicated moderate to high survey reliability. The vast majority (73.4%) of ICC values were indicative of good to excellent reliability between measurement methods. Bland-Altman plots verified method agreement, and 87% of pairwise t tests yielded an insignificant difference between information collected with the different administration methods.
The excellent compliance and the high level of consistency between data collected by paper and that collected by electronic methods indicate that the app provides a reliable means of cataloging real-time changes in PROs in SLE patients.
患者报告结局(PROs)能够提供有关疾病对个体影响的关键信息。利用移动技术以电子格式(ePRO)收集PRO数据,可在个体的日常环境中进行频繁评估。本研究的目的是评估系统性红斑狼疮(SLE)患者对手机应用程序(app)的依从性,并验证ePRO信息。
开发了一款从各种临床工具收集ePRO数据的智能手机应用程序。作为一项针对符合美国风湿病学会(ACR)SLE分类标准患者的多中心随机干预临床试验的一部分,通过ePRO和纸质管理工具收集信息。为了确定以不同格式收集的PRO信息之间的一致性,评估了组内相关系数(ICC)、配对学生t检验和Bland-Altman图。还评估了依从性和Cronbach's α作为调查可靠性的指标。
对于62名来自不同祖籍背景的受试者,ePRO完成的依从性很高(超过75%)。PROs的Cronbach α值表明调查可靠性为中度到高度。绝大多数(73.4%)的ICC值表明测量方法之间的可靠性良好到优秀。Bland-Altman图验证了方法的一致性,87%的配对t检验显示不同管理方法收集的信息之间差异不显著。
出色的依从性以及纸质收集数据与电子方法收集数据之间的高度一致性表明,该应用程序为记录SLE患者PROs的实时变化提供了一种可靠的手段。